BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24315369)

  • 1. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.
    Lourenco MV; Clarke JR; Frozza RL; Bomfim TR; Forny-Germano L; Batista AF; Sathler LB; Brito-Moreira J; Amaral OB; Silva CA; Freitas-Correa L; Espírito-Santo S; Campello-Costa P; Houzel JC; Klein WL; Holscher C; Carvalheira JB; Silva AM; Velloso LA; Munoz DP; Ferreira ST; De Felice FG
    Cell Metab; 2013 Dec; 18(6):831-43. PubMed ID: 24315369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in mice.
    Couturier J; Morel M; Pontcharraud R; Gontier V; Fauconneau B; Paccalin M; Page G
    J Biol Chem; 2010 Jan; 285(2):1272-82. PubMed ID: 19889624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.
    Ferreira ST; Klein WL
    Neurobiol Learn Mem; 2011 Nov; 96(4):529-43. PubMed ID: 21914486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Activators of Stress Kinase PKR within Human Genes That Control Splicing or Translation Create Novel Targets for Hereditary Diseases.
    Kaempfer R
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.
    Clarke JR; Lyra E Silva NM; Figueiredo CP; Frozza RL; Ledo JH; Beckman D; Katashima CK; Razolli D; Carvalho BM; Frazão R; Silveira MA; Ribeiro FC; Bomfim TR; Neves FS; Klein WL; Medeiros R; LaFerla FM; Carvalheira JB; Saad MJ; Munoz DP; Velloso LA; Ferreira ST; De Felice FG
    EMBO Mol Med; 2015 Feb; 7(2):190-210. PubMed ID: 25617315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.
    Forny-Germano L; Lyra e Silva NM; Batista AF; Brito-Moreira J; Gralle M; Boehnke SE; Coe BC; Lablans A; Marques SA; Martinez AM; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Neurosci; 2014 Oct; 34(41):13629-43. PubMed ID: 25297091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.
    Lourenco MV; Ferreira ST; De Felice FG
    Prog Neurobiol; 2015 Jun; 129():37-57. PubMed ID: 25857551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease.
    De Felice FG; Lourenco MV
    Front Aging Neurosci; 2015; 7():94. PubMed ID: 26042036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.
    Ferreira ST; Lourenco MV; Oliveira MM; De Felice FG
    Front Cell Neurosci; 2015; 9():191. PubMed ID: 26074767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
    Lambert MP; Barlow AK; Chromy BA; Edwards C; Freed R; Liosatos M; Morgan TE; Rozovsky I; Trommer B; Viola KL; Wals P; Zhang C; Finch CE; Krafft GA; Klein WL
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6448-53. PubMed ID: 9600986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
    Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges in developing relevant animal models for Alzheimer's disease.
    De Felice FG; Munoz DP
    Ageing Res Rev; 2016 Mar; 26():112-4. PubMed ID: 26829469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does brain insulin resistance develop in Alzheimer's disease?
    De Felice FG; Lourenco MV; Ferreira ST
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S26-32. PubMed ID: 24529521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons.
    Seixas da Silva GS; Melo HM; Lourenco MV; Lyra E Silva NM; de Carvalho MB; Alves-Leon SV; de Souza JM; Klein WL; da-Silva WS; Ferreira ST; De Felice FG
    J Biol Chem; 2017 May; 292(18):7395-7406. PubMed ID: 28302722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
    Yarchoan M; Toledo JB; Lee EB; Arvanitakis Z; Kazi H; Han LY; Louneva N; Lee VM; Kim SF; Trojanowski JQ; Arnold SE
    Acta Neuropathol; 2014 Nov; 128(5):679-89. PubMed ID: 25107476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease.
    Blázquez E; Velázquez E; Hurtado-Carneiro V; Ruiz-Albusac JM
    Front Endocrinol (Lausanne); 2014; 5():161. PubMed ID: 25346723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C neuroprotection against dose-dependent glutamate-induced neurodegeneration in the postnatal brain.
    Shah SA; Yoon GH; Kim HO; Kim MO
    Neurochem Res; 2015 May; 40(5):875-84. PubMed ID: 25701025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer's disease.
    Koo JH; Kwon IS; Kang EB; Lee CK; Lee NH; Kwon MG; Cho IH; Cho JY
    J Exerc Nutrition Biochem; 2013 Dec; 17(4):151-60. PubMed ID: 25566426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.